Related Experiment Video
Updated: Feb 8, 2026

Transfection of Mouse Retinal Ganglion Cells by in vivo Electroporation
Published on: April 17, 2011
The Nrf2 Signaling in Retinal Ganglion Cells under Oxidative Stress in Ocular Neurodegenerative Diseases
Xiu-Fen Liu1, Dan-Dan Zhou2, Tian Xie3
1Department of Ophthalmology, The First Hospital of Jilin University, Jilin, China.
Abstract:
Retinal ganglion cells (RGCs) are one of the important cell types affected in many ocular neurodegenerative diseases. Oxidative stress is considered to be involved in retinal RGCs death in ocular neurodegenerative diseases. More and more attention has been focused on studying the agents that may have neuroprotective effects. Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is a key nuclear transcription factor for the systemic antioxidant defense system. This review elucidates the underlying mechanism of the Nrf2-mediated neuroprotective effects on RGCs in ocular neurodegenerative diseases, such as diabetic retinopathy and retinal ischemia-reperfusion injury. Several Nrf2 inducers that shield RGCs from oxidative stress-induced neurodegeneration via regulating Nrf2 signaling are discussed.
Insights
Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) protects retinal ganglion cells (RGCs) from oxidative stress in neurodegenerative eye diseases. Nrf2 activators offer a promising therapeutic strategy for conditions like diabetic retinopathy.
Area of Science:
- Ophthalmology
- Neuroscience
- Molecular Biology
Background:
- Retinal ganglion cells (RGCs) are crucial for vision and vulnerable to neurodegeneration.
- Oxidative stress is a key factor in RGC death in ocular diseases.
- Identifying neuroprotective agents for RGCs is a significant research focus.
Purpose of the Study:
- To elucidate the mechanism of Nuclear factor (erythroid-derived 2)-like 2 (Nrf2)-mediated neuroprotection in RGCs.
- To review Nrf2's role in ocular neurodegenerative diseases, including diabetic retinopathy and retinal ischemia-reperfusion injury.
- To discuss Nrf2 inducers as potential therapeutic agents.
Main Methods:
- Literature review focusing on Nrf2 signaling pathways.
- Analysis of studies investigating oxidative stress and RGC death.
- Examination of therapeutic strategies involving Nrf2 activation.
Main Results:
- Nrf2 acts as a master regulator of the cellular antioxidant response.
- Nrf2 activation confers significant neuroprotection to RGCs against oxidative damage.
- Specific Nrf2 inducers demonstrate efficacy in preclinical models.
Conclusions:
- The Nrf2 pathway is a critical target for neuroprotection in RGCs.
- Targeting Nrf2 signaling presents a promising therapeutic avenue for ocular neurodegenerative diseases.
- Further research into Nrf2 inducers could lead to novel treatments.
More Related Videos
10:00Induction and Analysis of Oxidative Stress in Sleeping Beauty Transposon-Transfected Human Retinal Pigment Epithelial Cells
Published on: December 11, 2020
09:44Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
Published on: May 2, 2025
Related Concept Videos
Nitric Oxide Signaling Pathway
What is Cell Signaling?
Oxidation Numbers
Cell-surface Signaling
Paracrine Signaling
Pyruvate Oxidation
First, the enzyme pyruvate dehydrogenase removes the carboxyl group from pyruvate and releases it as carbon dioxide. The stripped molecule is then oxidized and releases electrons, which are then picked up by NAD+...